Table 1.

Baseline characteristics of patients in the immunology substudy of the Merck 035 triala

GroupNo. of patients (sex)Serum HIV-1 RNA (copies/ml)T cells/mm3
CD4+CD8+
A7 (M)54,535 ± 10,089147 ± 42711 ± 177
B3 (M)83,996 ± 43,766241 ± 60907 ± 81
C3 (M), 1 (F)89,001 ± 19,814205 ± 461,197 ± 124
  • a Values are means ± the SE.P was not significant for all comparisons, as determined by one-way ANOVA.